FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 11:00:48 10/05/2024 pm IST | ||
| 0.79 EUR | 0.00% |
|
| Current month | -52.41% | ||
| 1 month | -57.75% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/24/10 | 0.79 | 0.00% | 0 |
| 09/24/09 | 0.79 | -12.22% | 0 |
| 08/24/08 | 0.9 | -5.26% | 0 |
| 07/24/07 | 0.95 | 0.00% | 0 |
| 06/24/06 | 0.95 | +23.38% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 10, 2024 at 11:00 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UL5YA4 |
| ISIN | DE000UL5YA47 |
| Date issued | 14/07/2023 |
| Strike | 391.1 $ |
| Maturity | Unlimited |
| Parity | 90.44 : 1 |
| Emission price | 5.3 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.14 € |
|---|---|
| Lowest since issue | 0.63 € |
| Spread | 0.03 € |
| Spread % | 3.57% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
313.8
USD
Spread / Average Target
+1.18%
- Stock Market
- Certificates
- Certificat
